Handbook of Multiple Sclerosis - Couverture rigide

Couverture rigide

ISBN 10 : 0824797264 ISBN 13 : 9780824797263

Editeur : Marcel Dekker Inc, 1996

Synopsis

This work integrates the environmental triggers of multiple sclerosis (MS) with genetic susceptibility to the disease, and presents developments in MS investigation. It highlights epidemiology, aetiology, pathogenesis, pathology, clinical features, and therapy. The book explains the most efficacious treatment strategies, including beta interferons, copolymer 1, cladribine, imuran, methotrexate, corticosteroids, and IV gamma globulin as well as symptomatic therapies such as symmetrel, cylert, tegretol, dilantin, lioresol, antidepressants and ditropan.

A propos du livre

Présentation de l'éditeur

Reporting on the latest advances made in treating multiple sclerosis (MS) and continuing the high standards set by earlier editions, the Handbook of Multiple Sclerosis, Third Edition examines a wide range of topics from etiology to treatment options.

Analyzes recent developments in the natural history, immunopathology, lesion evolution, and therapy affecting MS treatment-including up-to-date research results from experimental therapies with t-cell vaccines, oral myelin, and monoclonal antibodies!

Summarizing previous breakthroughs and pointing the way toward future research, the Handbook of Multiple Sclerosis, Third Edition

provides a historical summary of the disease and examines the epidemiology and genetics of MS, including new evidence for and against an infectious etiology

investigates virus-induced demyelination, emphasizing models such as canine distemper (CDV), corona, visna, and herpes simplex viruses; the semliki forest virus (SFV); and animal models of autoimmune demyelination

notes the role of magnetic resonance imaging (MRI) in diagnosis, prognosis, natural history, and as a guide to therapy

explores the growing evidence for axonal damage as a major cause of disability in MS

summarizes the natural history of MS and delineates factors influencing exacerbations and progression of the disease

assesses current clinical and biological prognostic indicators for accurate diagnoses of MS as opposed to other idiopathic inflammatory demyelinating diseases (IIDDs) and evaluates the growing number of therapies for treating MS

and more!

Détails de l'édition

• Éditeur: Marcel Dekker Inc
• Date d'édition: 1996
• Langue: anglais
• ISBN 10: 0824797264
• ISBN 13: 9780824797263
• Reliure: Relié
• Numéro d'édition: 2
• Nombre de pages: 620
• Éditeur: Cook Stuart D.
• Coordonnées du fabricant: non disponible
• Personne responsable: non disponible